Skip to main content
Clinical Trials/JPRN-UMIN000041754
JPRN-UMIN000041754Completed未知

Predictors of abatacept efficacy in immunomics - PREDICTABA study

The University of Tokyo0 sites105 target enrollmentStarted: November 1, 2020Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Enrollment
105

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
20years-old to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • •Patients treated with more than 3 types of biologics previously Patients with a history of hypersensitivity to any of the ingredients of the abatacept product Patients with a concurrent condition secondary to malignancy Patients with active infection Patients who are pregnant or breastfeeding, or those wishing pregnancy, childbearing, or breastfeeding Patients ineligible for study participation in the opinion of the investigator or subinvestigator

Investigators

Similar Trials